Mary M. Moran

1.1k total citations
31 papers, 647 citations indexed

About

Mary M. Moran is a scholar working on Infectious Diseases, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Mary M. Moran has authored 31 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Economics and Econometrics. Recurrent topics in Mary M. Moran's work include SARS-CoV-2 and COVID-19 Research (7 papers), Respiratory viral infections research (6 papers) and Vaccine Coverage and Hesitancy (6 papers). Mary M. Moran is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Respiratory viral infections research (6 papers) and Vaccine Coverage and Hesitancy (6 papers). Mary M. Moran collaborates with scholars based in United States, United Kingdom and Germany. Mary M. Moran's co-authors include Lindsey Wu, Javier Guzmán, Nicole Jameson, Manuela Di Fusco, Alejandro Cané, Jennifer L. Nguyen, J. Jeffrey Malatack, Jay Lin, Santiago M. C. Lopez and Farid Khan and has published in prestigious journals such as Nature, The Lancet and PLoS ONE.

In The Last Decade

Mary M. Moran

27 papers receiving 615 citations

Peers

Countries citing papers authored by Mary M. Moran

Since Specialization

Citations

This map shows the geographic impact of Mary M. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary M. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary M. Moran more than expected).

Fields of papers citing papers by Mary M. Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary M. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary M. Moran. The network helps show where Mary M. Moran may publish in the future.

Co-authorship network of co-authors of Mary M. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Mary M. Moran. A scholar is included among the top collaborators of Mary M. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary M. Moran. Mary M. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Outcomes in Children <5 Years of Age Hospitalized for Respiratory Syncytial Virus, COVID-19 or Influenza in the United States 2025 ·The Pediatric Infectious Disease Journal ·Kathleen M. Andersen, (unknown), Deshayne B. Fell, (unknown), Mary M. Moran, Alejandro Cané, (unknown), Santiago M. C. Lopez	0
2	Comparison of COVID−19-associated inpatient burden by variant period in hospitalized children age <5 years in the United States 2025 ·Frontiers in Pediatrics ·Kathleen M. Andersen, (unknown), Alejandro Cané, Mary M. Moran, (unknown), Santiago M. C. Lopez	0
3	The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (≥ 65 Years Old) Adults 2024 ·Advances in Therapy ·J Langer, Verna Welch, Mary M. Moran, Alejandro Cané, Santiago M. C. Lopez, Amit Srivastava, Ashley Enstone, (unknown), (unknown), (unknown), (unknown), (unknown)	12
4	High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review 2023 ·Advances in Therapy ·(unknown), Verna Welch, Mary M. Moran, Alejandro Cané, Santiago M. C. Lopez, Amit Srivastava, Ashley Enstone, (unknown), (unknown), (unknown), (unknown), (unknown)	49
5	Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US 2023 ·Frontiers in Pediatrics ·Leah J. McGrath, Mary M. Moran, Tamuno Alfred, (unknown), Manuela Di Fusco, Farid Khan, Verna Welch, Deepa Malhotra, Alejandro Cané, Santiago M. C. Lopez	4
6	The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review 2023 ·Journal of Medical Economics ·(unknown), (unknown), Manuela Di Fusco, Jingyan Yang, (unknown), (unknown), Santiago M. C. Lopez, Mary M. Moran, Jennifer L. Nguyen, (unknown), (unknown), Meghan Gavaghan, (unknown), (unknown), Heather Burnett	7
7	Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron 2023 ·Journal of Patient-Reported Outcomes ·Manuela Di Fusco, Xiaowu Sun, Mary M. Moran, (unknown), Joann M. Zamparo, (unknown), Laura Puzniak, Ying P. Tabak, Joseph C. Cappelleri	20
8	The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths 2023 ·PLoS ONE ·Teresa K. Yamana, Marta Galanti, Sen Pei, Manuela Di Fusco, Frederick J. Angulo, Mary M. Moran, Farid Khan, David L. Swerdlow, Jeffrey Shaman	22
9	Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients 2022 ·Journal of Patient-Reported Outcomes ·Manuela Di Fusco, Xiaowu Sun, Mary M. Moran, (unknown), Joann M. Zamparo, Laura Puzniak, (unknown), Ying P. Tabak, Joseph C. Cappelleri	24
10	Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence 2020 ·Human Vaccines & Immunotherapeutics ·(unknown), Daniel A. Scott, Beate Schmöele-Thoma, Wendy Watson, Mary M. Moran, Raúl Istúriz	8
11	The Grand Convergence: Closing the Divide between Public Health Funding and Global Health Needs 2016 ·PLoS Biology ·Mary M. Moran	9
12	WHO plans for neglected diseases are wrong 2014 ·Nature ·Mary M. Moran	2
13	Registering New Drugs for Low-Income Countries: The African Challenge 2011 ·PLoS Medicine ·Mary M. Moran, Nathalie Strub‐Wourgaft, Javier Guzmán, Pascale Boulet, Lindsey Wu, Bernard Pécoul	31
14	Neglected Disease Research and Development: How Much Are We Really Spending? 2009 ·PLoS Medicine ·Mary M. Moran, Javier Guzmán, (unknown), (unknown), Nicole Jameson, (unknown), (unknown), Lindsey Wu	165
15	A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need 2005 ·PLoS Medicine ·Mary M. Moran	113
16	Correction: A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need 2005 ·PLoS Medicine ·Mary M. Moran	1
17	A Videotape to Improve Parental Knowledge of Lead Poisoning 2004 ·Ambulatory Pediatrics ·(unknown), (unknown), Mary M. Moran, Nancy D. Spector, (unknown), (unknown)	10
18	The G8 and access to medicines: no more broken promises 2003 ·The Lancet ·Mary M. Moran, Nathan Ford	3
19	Collaboration With School Nurses 2001 ·Archives of Pediatrics and Adolescent Medicine ·(unknown), Nancy D. Spector, (unknown), Mary M. Moran, (unknown), (unknown)	6
20	Isolated Congenital Malabsorption of Folic Acid in a Male Infant: Insights Into Treatment and Mechanism of Defect 1999 ·PEDIATRICS ·J. Jeffrey Malatack, Mary M. Moran, (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact